Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody designed to specifically bind to tissue factor pathway inhibitor (TFPI). This targeted interaction makes Befovacimab an essential tool for research into hemophilia A and B, providing insights into the regulation of the coagulation cascade and potential therapeutic interventions.
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody designed to specifically bind to tissue factor pathway inhibitor (TFPI). This targeted interaction makes Befovacimab an essential tool for research into hemophilia A and B, providing insights into the regulation of the coagulation cascade and potential therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
